Federal contract award
75R60220C00001
EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | PROGRAM SUPPORT CENTER ACQ MGMT SVC |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | Q517 — Pharmacy Services |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $34.0M |
| Current contract value | $34.0M |
| Potential contract value / ceiling | $34.0M |
| Start date | Jul 31, 2020 |
| Current end date | Jul 30, 2025 |
| Potential end date | Jul 30, 2025 |
| Latest award activity | Jul 31, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 31, 2024 | P00009 | $5.0M | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
| Jul 8, 2024 | P00008 | $785.8K | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
| Mar 27, 2024 | P00007 | $2.5M | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
| Jan 10, 2024 | P00006 | $3.0M | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
| Jun 30, 2023 | P00005 | $5.5M | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
| Mar 27, 2023 | P00004 | $3.1M | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
| Aug 15, 2022 | P00003 | $5.2M | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
| Jul 21, 2021 | P00002 | $4.8M | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
| Jul 31, 2020 | 0 | $4.0M | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
| Jul 31, 2020 | P00001 | $0 | EXPANDING PATIENT ACCESS TO HIV PRE-EXPOSURE PROPHYLAXIS (PREP)DRUGS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.